What is the Brooks Laboratories Ltd share price today?

The share price of NSE:BROOKS-EQ on 01 Oct 2026 (as of 15:03:14 IST) is ₹54.5.

What is the NSE:BROOKS-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:BROOKS-EQ 52 week high low range shows a high of ₹138.34 and a low of ₹36.3.

What is the Brooks Laboratories Ltd market cap?

As on 01 Oct 2026, Brooks Laboratories Ltd market cap is ₹1634880000.

What is the shareholding pattern of Brooks Laboratories Ltd Stock?

The shareholding pattern of Brooks Laboratories Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 52.62% Foreign Institutional Investors (FII): 0% Domestic Institutional Investors (DII): 0% Mutual Funds: 9.9% Retail & Others: 37.48% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Brooks Laboratories Ltd?

The Price-to-Earnings (PE) ratio of Brooks Laboratories Ltd is 12.3742, and the Price-to-Book (PB) ratio is 0.9004, as on 01 Oct 2026.

Brooks Laboratories Share Price

68.72+3.96 (+6.11%)

-46.36% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+6.11%

1 Week

-2.01%

1 Month

+4.61%

3 Month

-1.53%

6 Month

+1.69%

YTD

-14.25%

1 Year

-46.36%

5 Year

-48.38%

10 Year

-41.48%

Max

-30.62%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

65.46

63.30

52.97

44.56

36.29

High

71.70

73.45

75.60

79.69

130.97

About

Brooks Laboratories Limited (Brooks Laboratories) is a pharmaceutical contract research and manufacturing services company. It provides range of products catering to critical care segment in Parental Section, such as Beta Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

LAURUSLABSNSE

CIPLANSE

DRREDDYNSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

BROOKSNSE

LTP

1W Low

1W High

Market cap (₹)

1734.1-25.9 (-1.47%)

1725.50

1776.60

4,24,466Cr

9017.5-322.5 (-3.45%)

9002

9431.50

2,46,222Cr

4589.1-67.8 (-1.46%)

4551.80

4682

1,76,301Cr

1140.9+23.4 (2.09%)

1107.30

1150.90

1,12,818Cr

2030.8-5.8 (-0.28%)

2007.80

2069.20

1,10,823Cr

1307.4+6.4 (0.49%)

1300.20

1333.30

1,07,447Cr

1216.9+19.9 (1.66%)

1196.90

1250.70

1,03,471Cr

2328.8-39.7 (-1.68%)

2317.50

2426.80

97,850Cr

1667.9-25.1 (-1.48%)

1660.10

1715

96,836Cr

1951.7-4.8 (-0.25%)

1925.70

1964.90

89,629Cr

69.92-0.21 (-0.30%)

63.30

73.45

191Cr

Brooks Laboratories Share Price

68.72+3.96 (+6.11%)

-46.36% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years2%

3 years11%

Last year4%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year347%

Stock Price CAGR

10 years-6%

5 years-13%

3 years-17%

1 year-49%

Return on Equity

10 years-17%

5 years-16%

3 years-6%

Last year22%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	2%	11%	4%
-	-	-	347%
-6%	-13%	-17%	-49%
-17%	-16%	-6%	22%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

LAURUSLABS

CIPLA

DRREDDY

MANKIND

AUROPHARMA

LUPIN

BROOKS

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,746.4	₹424466 Cr	35.09	12.07	62.82	₹11479 Cr
9,023	₹246222 Cr	84.18	34.04	128.41	₹2568 Cr
4,580	₹176301 Cr	80.83	16.72	97.06	₹2163 Cr
1,124.7	₹112818 Cr	25	9.42	62.53	₹5040 Cr
2,036.9	₹110823 Cr	101.36	6.8	29.25	₹889 Cr
1,314.6	₹107447 Cr	31.88	9.77	57.87	₹3879 Cr
1,216	₹103471 Cr	32.11	5.32	63.99	₹4196 Cr
2,335	₹97850 Cr	47.9	13.75	71.08	₹1913 Cr
1,662.9	₹96836 Cr	26.08	17.95	96.84	₹3505 Cr
1,953.2	₹89629 Cr	16.21	30.95	154.35	₹5333 Cr
68.72	₹191 Cr	14.42	-0.61	5.03	₹25 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020
₹23 Cr	₹20 Cr	₹17 Cr	₹23 Cr	₹26 Cr	₹23 Cr	₹21 Cr	₹21 Cr	₹18 Cr	₹18 Cr	₹22 Cr	₹24 Cr	₹16 Cr	₹13 Cr	₹15 Cr	₹18 Cr	₹17 Cr	₹28 Cr	₹19 Cr	₹21 Cr	₹22 Cr	₹15 Cr	₹21 Cr	₹29 Cr
₹18 L	₹44 L	₹13 L	₹39 L	₹22 L	₹62 L	₹3 L	₹20 L	₹7 L	₹65 L	₹16 L	₹9 L	₹6 L	₹3 L	₹9 L	₹14 L	₹3 L	₹18 L	₹37 L	₹56 L	₹70 L	₹6 L	₹4 L	₹52 L
₹23 Cr	₹21 Cr	₹17 Cr	₹24 Cr	₹26 Cr	₹24 Cr	₹21 Cr	₹21 Cr	₹18 Cr	₹18 Cr	₹22 Cr	₹24 Cr	₹16 Cr	₹13 Cr	₹15 Cr	₹18 Cr	₹17 Cr	₹29 Cr	₹19 Cr	₹22 Cr	₹22 Cr	₹15 Cr	₹21 Cr	₹30 Cr
₹22 Cr	₹20 Cr	₹16 Cr	₹21 Cr	₹23 Cr	₹22 Cr	₹19 Cr	₹20 Cr	₹18 Cr	₹18 Cr	₹21 Cr	₹23 Cr	₹16 Cr	₹13 Cr	₹26 Cr	₹30 Cr	₹28 Cr	₹34 Cr	₹27 Cr	₹27 Cr	₹24 Cr	₹20 Cr	₹23 Cr	₹26 Cr
₹2 Cr	₹1 Cr	₹86 L	₹3 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹35 L	₹1 Cr	₹1 Cr	₹2 Cr	₹8 L	-₹9 L	-₹8 Cr	-₹9 Cr	-₹9 Cr	-₹4 Cr	-₹6 Cr	-₹4 Cr	₹33 L	-₹4 Cr	-₹62 L	₹6 Cr
₹21 L	₹9 L	₹16 L	₹28 L	₹30 L	₹26 L	₹28 L	₹32 L	₹16 L	₹27 L	₹21 L	₹19 L	₹17 L	₹18 L	₹75 L	₹63 L	₹62 L	₹84 L	₹74 L	₹75 L	₹76 L	₹74 L	₹78 L	₹80 L
₹1 Cr	₹61 L	₹30 L	₹2 Cr	₹3 Cr	₹2 Cr	₹94 L	₹96 L	-₹21 L	₹30 L	₹60 L	₹1 Cr	-₹53 L	-₹71 L	-₹11 Cr	-₹12 Cr	-₹11 Cr	-₹7 Cr	-₹9 Cr	-₹7 Cr	-₹2 Cr	-₹6 Cr	-₹3 Cr	₹3 Cr
₹1 Cr	₹61 L	₹30 L	₹2 Cr	₹3 Cr	₹1 Cr	₹94 L	₹96 L	-₹21 L	₹30 L	₹58 L	₹1 Cr	-₹53 L	-₹71 L	-₹9 Cr	-₹8 Cr	-₹9 Cr	-₹6 Cr	-₹7 Cr	-₹5 Cr	-₹1 Cr	-₹17 Cr	-₹3 Cr	₹3 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
—	—	—	—	—	—
₹29 Cr	₹29 Cr	₹26 Cr	₹25 Cr	₹25 Cr	₹25 Cr
₹93 Cr	₹69 Cr	₹39 Cr	₹49 Cr	₹63 Cr	₹54 Cr
₹93 Cr	₹69 Cr	₹39 Cr	₹49 Cr	₹63 Cr	₹54 Cr
₹123 Cr	₹98 Cr	₹66 Cr	₹74 Cr	₹87 Cr	₹79 Cr
₹0	₹0	₹0	₹0	₹47 Cr	₹0
₹1 Cr	₹13 L	₹0	₹0	₹9 Cr	₹14 Cr
₹0	₹0	₹0	₹0	-₹1 Cr	₹3 Cr
₹1 Cr	₹2 Cr	₹89 L	₹1 Cr	₹1 Cr	₹10 L
₹1 Cr	₹88 L	₹93 L	₹1 Cr	₹2 Cr	₹2 Cr
₹4 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹11 Cr	₹19 Cr
—	—	—	—	—	—
₹11 Cr	₹14 Cr	₹15 Cr	₹23 Cr	₹28 Cr	₹31 Cr
₹3 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹9 Cr	₹18 Cr
₹6 Cr	₹6 Cr	₹5 Cr	₹6 Cr	₹11 Cr	₹14 Cr
₹1 Cr	₹95 L	₹64 L	₹1 Cr	₹1 Cr	₹1 Cr
₹22 Cr	₹23 Cr	₹23 Cr	₹33 Cr	₹49 Cr	₹64 Cr
₹148 Cr	₹124 Cr	₹90 Cr	₹110 Cr	₹195 Cr	₹162 Cr
₹123 Cr	₹76 Cr	₹71 Cr	₹20 Cr	₹24 Cr	₹7 Cr
₹7 Cr	₹6 Cr	₹5 Cr	₹6 Cr	₹24 Cr	₹31 Cr
—	—	—	—	—	—
₹26 Cr	₹25 Cr	₹23 Cr	₹23 Cr	₹143 Cr	₹133 Cr
₹11 Cr	₹11 Cr	₹10 Cr	₹8 Cr	₹33 Cr	₹26 Cr
₹15 Cr	₹14 Cr	₹14 Cr	₹15 Cr	₹110 Cr	₹108 Cr
₹1 Cr	₹0	₹0	₹0	₹15 Cr	₹68 L
₹92 Cr	₹74 Cr	₹43 Cr	₹64 Cr	₹6 L	₹2 L
₹92 Cr	₹74 Cr	₹43 Cr	₹64 Cr	₹6 L	₹2 L
₹3 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹8 Cr	₹3 Cr
₹14 L	₹9 L	₹13 L	₹17 L	₹22 L	₹31 L
₹111 Cr	₹90 Cr	₹59 Cr	₹82 Cr	₹133 Cr	₹112 Cr
—	—	—	—	—	—
₹11 Cr	₹9 Cr	₹10 Cr	₹11 Cr	₹28 Cr	₹24 Cr
₹16 Cr	₹20 Cr	₹16 Cr	₹13 Cr	₹18 Cr	₹14 Cr
₹8 Cr	₹1 Cr	₹69 L	₹1 Cr	₹4 Cr	₹2 Cr
₹53 L	₹1 Cr	₹2 Cr	₹40 L	₹2 Cr	₹65 L
₹2 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹11 Cr	₹8 Cr
₹37 Cr	₹34 Cr	₹31 Cr	₹28 Cr	₹61 Cr	₹47 Cr
₹16 Cr	₹11 Cr	₹8 Cr	-₹5 Cr	₹12 Cr	-₹16 Cr
₹148 Cr	₹124 Cr	₹90 Cr	₹110 Cr	₹195 Cr	₹162 Cr
₹42	₹33	₹25	₹30	₹35	₹32
₹42	₹33	₹25	₹30	₹35	₹32

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
₹25 Cr	-₹10 Cr	-₹20 Cr	-₹38 Cr	-₹24 Cr	-₹9 Cr
-₹17 Cr	₹14 Cr	₹23 Cr	₹13 Cr	₹11 Cr	₹10 Cr
₹2 Cr	-₹3 Cr	-₹13 Cr	₹11 Cr	-₹24 Cr	₹7 Cr
₹9 Cr	₹2 Cr	-₹10 Cr	-₹14 Cr	-₹37 Cr	₹9 Cr
₹9 Cr	₹3 Cr	-₹10 Cr	-₹14 Cr	-₹37 Cr	₹4 Cr
-₹3 Cr	-₹45 Cr	₹18 L	₹49 L	-₹25 Cr	-₹5 Cr
₹17 L	₹42 Cr	₹10 Cr	₹11 Cr	₹64 Cr	₹1 Cr
₹7 Cr	-₹8 L	₹10 L	-₹3 Cr	₹2 Cr	₹49 L
₹4 L	₹13 L	₹2 L	₹3 Cr	₹88 L	₹40 L
₹7 Cr	₹4 L	₹13 L	₹2 L	₹3 Cr	₹88 L

Fundamental Ratios

Consolidated

Standalone

No results found

Brooks Laboratories Share Price

68.72+3.96 (+6.11%)

-46.36% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Open a free Demat account in minutes to start investing and screening .

Brooks Laboratories Share Price

68.72+3.96 (+6.11%)

-46.36% past 1 Year

Shareholding summary

Promoters

52.62%

FII

DII

9.9%

Others

37.48%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
52.62%	52.62%	52.62%	52.62%	52.62%	52.62%
0.00%	0.17%	0.09%	0.01%	0.00%	0.05%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
9.90%	9.90%	9.90%	9.90%	9.90%	9.90%
37.48%	37.31%	37.39%	37.47%	37.48%	37.43%

Bulk & block deals

Name

Amit Kumar Jain

Ramesh Thakurdas Jaisinghani

One Up Financial Consultants Pvt Ltd

Rr Family Trust

Aryan Mahajan

Atul Ranchal

Saravana Global Holdings Limited

Mukul Maheshwari (Huf)

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
08 Oct 2026	Purchase	1.81 Cr	₹70.26	2.58 L	Bulk	0.87599	NSE
08 Oct 2026	Sell	1.95 Cr	₹70.24	2.78 L	Bulk	0.943953	NSE
08 May 2026	Sell	86.34 L	₹50.55	1.71 L	Bulk	0.579834	NSE
14 Nov 2024	Purchase	5.46 Cr	₹136.40	4 L	Bulk	1.357902	NSE
14 Nov 2024	Purchase	3 Cr	₹137.40	2.18 L	Bulk	0.741075	BSE
14 Nov 2024	Sell	6.60 Cr	₹137.40	4.80 L	Bulk	1.629483	BSE
14 Nov 2024	Sell	5.39 Cr	₹136.40	3.95 L	Bulk	1.340966	NSE
14 Nov 2024	Sell	2.75 Cr	₹137.40	2 L	Bulk	0.678951	BSE
16 May 2024	Sell	1.27 Cr	₹92.12	1.38 L	Bulk	0.469827	NSE
21 Apr 2022	Purchase	1.38 Cr	₹104.67	1.32 L	Bulk	0.44694	NSE

Insider trading & SAST

Client name

Aryan Mahajan

Atul Ranchal & Pacs

Saras Gupta

Atul Ranchal

Saras Gupta

Atul Ranchal

Aryan Mahajan

Davinder Kumari (Revised)

Erwin Mahajan

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
22 Nov 2024	Promoter	Disposal	1.83	2.77	0	—	4.80 L	14 Nov 2024	Market	7,26,490	SAST	29(2)	—
22 Nov 2024	Promoter	Disposal	4.54	59.06	0	—	11.90 L	14 Nov 2024	Market	1,55,00,292	SAST	29(2)	—
22 Nov 2024	Promoter	Disposal	0.44	2.63	0	—	1.15 L	14 Nov 2024	Market	6,90,143	SAST	29(2)	—
22 Nov 2024	Promoter	Disposal	2.27	21.6	0	—	5.95 L	14 Nov 2024	Market	56,68,060	SAST	29(2)	—
17 Nov 2024	Promoter	Disposal	0.762001	21.6	2.75 Cr	₹137.40	2 L	14 Nov 2024	Market Sale	56,68,060	Insider Trading	—	Equity Shares
17 Nov 2024	Promoter Group	Disposal	0.43969	2.63	1.59 Cr	₹137.40	1.15 L	14 Nov 2024	Market Sale	6,90,143	Insider Trading	—	Equity Shares
17 Nov 2024	Promoter	Disposal	1.504993	22.36	5.39 Cr	₹136.40	3.95 L	14 Nov 2024	Market Sale	58,68,060	Insider Trading	—	Equity Shares
17 Nov 2024	Promoter Group	Disposal	1.828801	2.77	6.60 Cr	₹137.40	4.80 L	14 Nov 2024	Market Sale	7,26,490	Insider Trading	—	Equity Shares
31 Aug 2023	Promoter Group	Acquisition	0.017899	0.15	3.52 L	₹75	4.70 K	30 Aug 2023	Public Right	40,678	Insider Trading	—	Equity Shares
31 Aug 2023	Promoter Group	Acquisition	0.270396	4.6	7.10 L	₹10	70.97 K	30 Aug 2023	Public Right	12,06,490	Insider Trading	—	Equity Shares

Brooks Laboratories Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Brooks Laboratories Share Price

Brooks Laboratories Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Brooks Laboratories Share Price

Brooks Laboratories Share Price

Oscillators

Moving averages

Brooks Laboratories Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Brooks Laboratories Share Price

Corporate Actions

Company details

Brooks Laboratories Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Brooks Laboratories Share Price

News

Brooks Laboratories informs about trading window closure

Brooks Laboratories informs about newspaper publication

Brooks Laboratories reports Profit after tax of 30.30 Lakhs, in the December 2025 quarter

Brooks Laboratories reports Profit after tax of 2.24 Crores, in the September 2025 quarter

Brooks Laboratories reports Profit after tax of 72.40 Lakhs, in the December 2024 quarter

Brooks Laboratories - Quaterly Results

Brooks Laboratories - Quaterly Results

Brooks Laboratories: Co Approves Fund Raise Of Up To 75.00 Crores Rupees || Fund Raise Through Issue Of Equity Shares On Preferential Basis

Brooks Laboratories - Quaterly Results

Brooks Laboratories reports Profit after tax of Rs -21.20 Lakhs, in the June 2024 quarter

Brooks Laboratories - Quaterly Results

Brooks Laboratories - Quaterly Results

Brooks Laboratories - Quaterly Results

Brooks Laboratories reports Profit after tax of 57.70 Lakhs, in the December 2023 quarter

Brooks Laboratories informs about board meeting

Brooks Laboratories: Board Meeting On Jan 24 To Consider And Approve Fund Raising Through Rights Issue

Brooks Laboratories: Co Says Fixed 11.58 Crores Rupees As Right Issue Size || Right Issue Price At 75 Rupees Per Share

Brooks Laboratories informs about resignation of director

Brooks Laboratories reports Profit after tax of Rs -72.10 Lakhs, in the March 2023 quarter

Brooks Laboratories informs about clarification

Brooks Laboratories Ltd Share Price Today

Brooks Laboratories Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator